IFNG and diabetes mellitus: As diabetes is a key risk factor for presentation with melioidosis and diabetics are likely a prime target group for vaccination, diabetes-associated dysregulation of T cell immune responses to melioidosis, particularly related to impaired IFN-γ production, has been well characterized [15–17].